RE:RE:RE:RE:RE:Speechless - Fire them all, really.Those freebie warrants may prove to be a blessing in disguise for us as it does alter the incentives for Marathon in a meaningful way and aligns them more with common shareholders interests, assumeing the situation at THTX does not totally fall apart. I see no evidence at the moment that it is totally falling apart and note that Marathon undoubtedly extended the $20 million knowing THTX would fall below the $20 million level in the loan agreement and they have not told THTX to shut down the cancer research effort totally in order to focus 100% on repaying their loan. I suspect they have an eye on the upside of their warrants and know cancer could provide for that even though the loan was worked out only focusing on the legacy drug business.
PWIB123 wrote: I don't disagree with much of this, but Marathon got a freebie in terms of upside with warrants. Let's not be fooled in that their number one priority is to get repaid first. On the inventory front, they've already given warning that they'll likely have an issue with existing inventory that "might" expire. It likely will. I understood the customer issue, but they still ended up taking a hit in the end by way of adjusting revenue and apparently making it a part of their customer negotiation...assuming I read that correctly. I've just never seen a company have so many setbacks in the midst of so many opportunities for upside. History tends to repeat itself.